Submitted by Anonymous (not verified) on 12 October 2023 - 14:55
Opinion/decision on a Paediatric investigation plan (PIP): Bimervax,SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer – B.1.351-B.1.1.7 strains, decision type: , therapeutic area: , PIP number: P/0465/2022
Source: